Camden, New Jersey 08103


Purpose:

The objective of this research is to determine if the addition of the Clear Guide ONE, a Computer Assisted Instrument Guidance (CAIG) system, provides improvement over existing ultrasound guided, needle-based procedures for peripheral nerve blocks. The ultrasound can visualize the targeted vessel or nerve, but the addition of the CAIG may help the clinician better guide the needle to the target.


Study summary:

This pilot study will be a randomized, single-blinded control trial. The clinicians cannot be blinded, but the person questioning the patient post-op to determine success rate will be blinded. There will be two randomized groups of patients: control and test. The control group will receive the procedure with traditional methods and equipment currently in use at Cooper University. The test group will receive the same procedure utilizing existing ultrasound equipment with the supplemental CAIG system.


Criteria:

Inclusion Criteria: - Undergoing orthopedic surgery who are candidates for peripheral nerve blocks for control of postoperative pain - Able to give written informed consent Exclusion Criteria: - Unable to give informed consent - Patients in whom regional anesthesia is contradicted


NCT ID:

NCT02614222


Primary Contact:

Principal Investigator
Ronak Desai, DO
The Cooper Health System

Ronak Desai, DO
Phone: 856-342-2000
Email: desai-ronak@cooperhealth.edu


Backup Contact:

Email: Shapiro-Ashley@CooperHealth.edu
Ashley Shapiro, BA
Phone: 856-968-7333


Location Contact:

Camden, New Jersey 08103
United States

Ronak Desai, DO
Phone: 856-342-2000
Email: desai-ronak@cooperhealth.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.